MammerTyper® is an innovative molecular in vitro diagnostic test (IVD) which determines the expression status of the four most important breast cancer biomarkers ERBB2 (HER2), ESR1 (ER), PGR (PR) and MKI67 (marker of proliferation Ki-67) in a quantitative and reproducible way by means of RT-qPCR.
BÜHLMANN Laboratories AG
Baselstr. 55
4124 Schönenbuch
Switzerland
Fon: +41 61 487 12 12
Fax: +41 61 487 12 34
E-Mail: info@buhlmannlabs.ch
Social Links